{"slug":"ss-31-glp1-gut","verification":{"valid":true,"entries":2,"head":"446ca43d0f7147c2f5b46b09203a26cae9d2b1cbcbedbd94849830d11fde2e87"},"energy":{"passes":2,"tokens_in":19395,"tokens_out":3668,"tokens_total":23063,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"446ca43d0f7147c2f5b46b09203a26cae9d2b1cbcbedbd94849830d11fde2e87"},"provenance":[{"ts":"2026-06-29T23:54:06.224Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Ss 31 for Glp1 Gut\nSlug: ss-31-glp1-gut\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"GLP-1 gut damage / gastroparesis\",\"condition_key\":\"glp1-gut-damage\",\"primary_peptide\":\"ss-31\",\"peptides_in_scope\":[{\"id\":\"ss-31\",\"name\":\"SS-31 (Elamipretide)\"}],\"drugs_in_scope\":[\"glp1-agonists\"],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have GLP-1 gut damage / gastroparesis\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"ss-31\",\"name\":\"SS-31 (Elamipretide)\",\"section_title\":\"Why SS-31 (Elamipretide) might help you\",\"layer\":\"mitochondrial\",\"steps\":[\"You are reading about **GLP-1 gut damage / gastroparesis** — what breaks down matters before any compound name.\",\"**Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. You are reading about **GLP-1 gut damage / gastroparesis** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[{\"drug\":\"glp1-agonists\",\"name\":\"GLP-1 agonists (class)\",\"section_title\":\"Why GLP-1 agonists (class) matters for you\",\"steps\":[\"**Drug:** GLP-1 agonists (class)\",\"**What it does:** Metabolic benefit vs gut slowing / muscle loss trade","response":"{\n  \"slug\": \"ss-31-glp1-gut\",\n  \"title\": \"SS-31 (Elamipretide) for GLP-1 Agonist Gut Damage: Mitochondrial Evidence Review\",\n  \"body\": \"## What's breaking down if you have GLP-1 gut damage / gastroparesis\\n\\nGLP-1 agonists slow gastric emptying as part of their metabolic action. In some people this effect becomes excessive and leads to symptoms of gastroparesis. The stomach and small intestine rely on smooth muscle cells and enteric neurons that need steady ATP from mitochondria to contract and coordinate movement. When mitochondria in these cells produce excess reactive oxygen species or lose efficient electron transport, energy drops and motility slows further. Oxidative damage to cardiolipin in the inner mitochondrial membrane can worsen cristae structure and ATP output. If your GLP-1 use coincides with persistent delayed emptying, one layer of the problem may be mitochondrial stress in gut tissue rather than only the drug's direct receptor effect. Repair pathways that target this mitochondrial layer differ from simply stopping the drug or masking symptoms.\\n\\n## Why SS-31 (Elamipretide) might help you\\n\\n1. You are reading about GLP-1 gut damage / gastroparesis — what breaks down matters before any compound name.\\n2. Therefore for you: If mitochondrial dysfunction in enteric smooth muscle or neurons is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair at the cardiolipin level inside mitochondria — not because it masks slowed emptying.\\n\\nSS-31 binds directly to cardiolipin in the inner mitochondrial membrane. This interaction stabilizes cristae structure and supports electron transport chain efficiency. When cardiolipin is protected, electron leak drops and reactive oxygen species production falls. Cells regain better ATP output without the drug needing to act on GLP-1 receptors themselves. In gut tissue where mitochondria are strained, restoring this layer could support the energy needed for normal motility once the primary drug ","tokens_in":19395,"tokens_out":3668,"cost":0,"prev":"genesis","hash":"3d6bda0df15c78e1ff960720eee6ff877f08592bc44338986ce871bda967a51e"},{"ts":"2026-07-17T02:42:03.812Z","model":"owner","action":"voxel_divide","prompt":"","input":"ss-31-glp1-gut","response":"24 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"3d6bda0df15c78e1ff960720eee6ff877f08592bc44338986ce871bda967a51e","hash":"446ca43d0f7147c2f5b46b09203a26cae9d2b1cbcbedbd94849830d11fde2e87"}]}